Diethylamine

Diethylamine

SCHEMBL9700231

CC1COc2ccccc2N1N.CCNCC

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 1/20 0.40
ESR2 Q92731 1/20 0.40
MAPT P10636 1/20 0.38
CA2 P00918 1/20 0.36
LTA4H P09960 2/20 0.36
GAA P10253 1/20 0.36
HSD11B1 P28845 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL9699242 0.79 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL11007300 0.73 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
Diethylamine SCHEMBL9699235 0.72 MEN1 (0.40) MEN1KMT2APOLBALDH1A1LMNA
SCHEMBL15222055 0.71 SMN1; SMN2 (0.54) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL680143 0.71 SMN1; SMN2 (0.54) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL9700421 0.70 SMN1; SMN2 (0.38) SMN1; SMN2POLBALDH1A1LMNAMAPT
SCHEMBL9700223 0.70 LTA4H (0.42) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL29066267 0.69 SMN1; SMN2 (0.52) SMN1; SMN2MEN1KMT2APOLBALDH1A1
SCHEMBL31693816 0.68 HCRTR2 (0.42) MEN1KMT2APOLBCA2
SCHEMBL19418286 0.68 NR3C2 (0.44) MEN1KMT2AALDH1A1CA2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5112820-A Vision defects STERLING DRUG INC. (US) 1992-05-12 US disclosed
US-5109135-A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates STERLING DRUG INC. (US) 1992-04-28 US disclosed
US-5066803-A Chemical intermediates for analgesics STERLING DRUG INC. (US) 1991-11-19 US disclosed
US-4939138-A 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines STERLING DRUG INC. (US) 1990-07-03 US disclosed